Bottom line
How much do VGHCX and IXJ overlap?
55% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 45.4% of VGHCX's assets and 48.3% of IXJ's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings VGHCX and IXJ have in common
| Holding | % of VGHCX | % of IXJ | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 8.61% | 10.93% | 8.61% |
| Merck & Co Inc | 5.44% | 4.12% | 4.12% |
| Johnson & Johnson | 4.83% | 7.04% | 4.83% |
| AstraZeneca PLC | 4.59% | 3.76% | 3.76% |
| UnitedHealth Group Inc | 4.05% | 4.40% | 4.05% |
| Gsk Plc | 3.00% | 1.38% | 1.38% |
| Intuitive Surgical Inc | 2.52% | 1.83% | 1.83% |
| CVS Health Corp | 2.52% | 1.71% | 1.71% |
| Vertex Pharmaceuticals Inc | 2.36% | 1.64% | 1.64% |
| AbbVie Inc | 2.30% | 5.12% | 2.30% |
| Danaher Corp | 2.18% | 1.56% | 1.56% |
| Elevance Health Inc | 1.83% | 1.09% | 1.09% |
| Roche Holding AG | 1.18% | 3.75% | 1.18% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in VGHCX
- Edwards Lifesciences Corp — 2.56%
- Cencora Inc — 2.47%
- Regeneron Pharmaceuticals Inc — 2.14%
- Novartis AG — 1.91%
- Argenx SE — 1.68%
- HCA Healthcare Inc — 1.68%
- Ucb Sa — 1.67%
- Boston Scientific Corp — 1.53%
- Agilent Technologies Inc — 1.49%
- Biogen Inc — 1.46%
- Galderma Group AG — 1.37%
- Dexcom Inc — 1.18%
Only in IXJ
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
- Abbott Laboratories — 2.05%
- Gilead Sciences, Inc. — 2.04%
- Novo Nordisk A/s — 1.99%
- Pfizer Inc. — 1.78%
- Bristol-myers Squibb Company — 1.53%
- Stryker Corporation — 1.41%
- Medtronic Public Limited Company — 1.30%
- Sanofi Sa — 1.18%
- Mckesson Corporation — 1.18%
Asset mix
| Asset type | VGHCX | IXJ |
|---|---|---|
| Stocks | 97.6% | 99.6% |
| Repurchase agreements | 2.2% | — |
| Cash & short-term funds | 0.1% | 1.3% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | VGHCX | IXJ |
|---|---|---|
| US | 77.6% | 70.6% |
| CH | 4.5% | 10.4% |
| GB | 7.6% | 5.8% |
| JP | 4.8% | 3.7% |
| BE | 3.4% | 0.5% |
| DK | 1.4% | 2.3% |
| FR | — | 2.0% |
| DE | — | 1.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do VGHCX and IXJ overlap?
What stocks do VGHCX and IXJ have in common?
Should I own both VGHCX and IXJ?
Which holds more stocks, VGHCX or IXJ?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.